-
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | IL0011063760 |
| Sector | Healthcare |
| Market Cap | 45M |
|---|---|
| PE Ratio | None |
| Target Price | 33.56 |
| Beta | 0.33 |
| Dividend Yield | None |
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for INCR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026